Dexcom (DXCM)

Stock-Based Compensation

$162.40M

TTM · Period ending: · USD

DXCM logo

DXCM Stock-Based Compensation

Latest reported$162.40M
DXCM TTM Stock-Based Comp ($1.67B → $162.40M)
High-resolution chart · PNG

DXCM stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Dexcom Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
162,400,000
168,700,000
159,600,000
167,900,000
166,200,000
165,600,000
170,400,000
164,000,000
159,600,000
154,600,000
150,800,000
147,900,000
139,700,000
132,600,000
126,500,000
118,800,000
115,500,000
114,500,000
113,400,000
121,200,000
124,400,000
123,500,000
119,400,000
108,900,000
102,600,000
101,600,000
102,700,000
103,700,000
106,400,000
102,300,000
101,900,000
102,200,000
100,500,000
100,200,000
106,200,000
110,400,000
114,000,000
116,300,000
110,800,000
105,200,000
98,800,000
91,900,000
82,700,000
73,500,000
64,700,000
57,200,000
50,000,000
42,300,000
35,100,000
28,300,000
24,600,000
22,542,000
20,821,000
19,254,000
18,400,000
17,438,000
16,287,000
15,111,000
13,513,000
2,570,000
1,159,000
273,000
0
9,517,000
9,330,000
8,600,000
8,366,000
6,212,000
4,082,000
2,041,000
1,948,000
8,070,000
8,070,000
8,070,000
7,218,000
5,853,997,000
5,854,399,841
5,854,880,415
7,142,552,415
2,955,223,415
2,954,820,574
2,954,340,000
1,666,153,123
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.